Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Alan, Rembach"'
Autor:
Marcela Cespedes, Kelly R. Jacobs, Paul Maruff, Alan Rembach, Christopher J. Fowler, Brett Trounson, Kelly K. Pertile, Rebecca L. Rumble, Stephanie R. Rainey-Smithe, Christopher C. Rowe, Victor L. Villemagne, Pierrick Bourgeat, Chai K. Lim, Pratishtha Chatterjee, Ralph N. Martins, Arne Ittner, Colin L. Masters, James D. Doecke, Gilles J. Guillemin, David B. Lovejoy
Publikováno v:
Neurobiology of Disease, Vol 171, Iss , Pp 105783- (2022)
Increasing evidence suggests that kynurenine pathway (KP) dyshomeostasis may promote disease progression in dementia. Studies in Alzheimer's disease (AD) patients confirm KP dyshomeostasis in plasma and cerebrospinal fluid (CSF) which correlates with
Externí odkaz:
https://doaj.org/article/75df2cb1e7904b2c830ffb9d9588ebf8
Autor:
Veer Bala Gupta, James D. Doecke, Eugene Hone, Steve Pedrini, Simon M. Laws, Madhav Thambisetty, Ashley I. Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, Stuart Lance Macaulay, Alan Rembach, Stephanie R. Rainey‐Smith, Ralph N. Martins, AIBL Research Group
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 3, Iss 1, Pp 18-26 (2016)
Abstract Introduction For early detection of Alzheimer's disease (AD), the field needs biomarkers that can be used to detect disease status with high sensitivity and specificity. Apolipoprotein J (ApoJ, also known as clusterin) has long been associat
Externí odkaz:
https://doaj.org/article/e67ea23dc1304ec49222744d11085b49
Autor:
Ying Xia, Vincent Dore, Victor L. Villemagne, Brendan S. Silbert, Jurgen Fripp, James D. Doecke, Elise J Harrison, Adrian Kamer, Robert Grenfell, Madeline Peretti, Simon McBride, Christopher C. Rowe, Paul Maruff, Lidija Milicic, Kelly K. Pertile, Steven J. Collins, Tania Taddei, Christine Thai, Andrea G. Louey, Michael Weinborn, Richard Head, Pierrick Bourgeat, Colin L. Masters, Olivier Salvado, Sabine Bird, S. Lance Macaulay, Rebecca L. Rumble, Michael Vacher, Simon Gibson, Lucy Lim, Amir Fazlollahi, Samantha C. Burnham, Kathryn A. Ellis, Yen Ying Lim, Regan Tyrrell, Julia Bomke, Michael Woodward, Belinda M. Brown, Joanne Robertson, Brett Trounson, Simon M. Laws, Carolyn Chadunow, Magdalene Soh, Liang Jin, Morgan Radler, Greg Savage, Christopher Fowler, Ralph N. Martins, Samantha L. Gardener, Fiona Lamb, Mark Rodrigues, Lucy Mackintosh, David Ames, Stephanie R. Rainey-Smith, Lis Evered, Alan Rembach, Tenielle Porter, Qiao-Xin Li, Nicola T. Lautenschlager, Shiji Varghese, Ashley I. Bush, Hamid R. Sohrabi, Kevin Taddei
Publikováno v:
Journal of Alzheimer's Disease Reports
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study commenced in 2006 as a prospective study of 1,112 individuals (768 cognitively normal (CN), 133 with mild cognitive impairment (MCI), and 211 with Alzheimer’s disease dementi
Autor:
Alan Rembach, Dominic J. Hare, Monica Lind, Christopher J. Fowler, Robert A. Cherny, Catriona McLean, Ashley I. Bush, Colin L. Masters, Blaine R. Roberts
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2013 (2013)
Alzheimer’s disease (AD) is the leading cause of dementia and represents a significant burden on the global economy and society. The role of transition metals, in particular copper (Cu), in AD has become of significant interest due to the dyshomeos
Externí odkaz:
https://doaj.org/article/9f59acaf8342418da0d0b1d0047d106e
Autor:
Victor L. Villemagne, Shaun Frost, Prita R. Asih, Kevin Taddei, James D. Doecke, Eugene Hone, Samantha C. Burnham, Kathryn A. Ellis, Giuseppe Verdile, Ralph N. Martins, Veer Bala Gupta, Simon M. Laws, Olivier Salvado, David Ames, Ian Martins, Pratishtha Chatterjee, Wei Ling Lim, Christopher C. Rowe, Sunil Gupta, Eka J. Wahjoepramono, Tejal M. Shah, Belinda M. Brown, Sam Gandy, Kathryn Goozee, Sid E. O'Bryant, Colin L. Masters, Paul E. Fraser, Binosha Fernando, Alan Rembach, Steve Pedrini, Prashant Bharadwaj, Samantha L. Gardener, Stephanie R. Rainey-Smith, Stephanie J. Fuller, Hamid R. Sohrabi, Ashley I. Bush, Anna M. Barron
Publikováno v:
Journal of Alzheimer's Disease
Worldwide there are over 46 million people living with dementia, and this number is expected to double every 20 years reaching about 131 million by 2050. The cost to the community and government health systems, as well as the stress on families and c
Autor:
Wiesje M. van der Flier, Marissa D. Zwan, Robyn Veljanoski, S. Lance Macaulay, Robert Williams, Philip Scheltens, Laura Margison, Alan Rembach, Olivier Salvado, Victor L. Villemagne, Christopher C. Rowe, Pierrick Bourgeat, Ralph N. Martins, David Ames, Kathryn A. Ellis, Colin L. Masters, Vincent Dore, Rachel F. Buckley
Publikováno v:
Journal of Alzheimer's Disease. 49:1115-1122
Background: APOE ɛ4 genotype and aging have been identified as risk factors for Alzheimer’s disease (AD). In addition, subjective memory complaints (SMC) might be a first clinical expression of the effect of AD pathology on cognitive functioning.
Autor:
David Ames, Christopher C. Rowe, Colin L. Masters, S L Macaulay, Simon M. Laws, Veer Bala Gupta, Victor L. Villemagne, Alan Rembach, Eugene Hone, Stephanie R. Rainey-Smith, Ralph N. Martins, Ashley I. Bush, Madhav Thambisetty, James D. Doecke, Steve Pedrini
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 3, Iss 1, Pp 18-26 (2016)
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Introduction For early detection of Alzheimer's disease (AD), the field needs biomarkers that can be used to detect disease status with high sensitivity and specificity. Apolipoprotein J (ApoJ, also known as clusterin) has long been associated with A
Autor:
Michael M. Saling, Colin L. Masters, Rachel F. Buckley, Christopher C. Rowe, Paul Maruff, Kathryn A. Ellis, Greg Savage, Stephanie R. Rainey-Smith, S. Lance Macaulay, Alan Rembach, David Ames, Ralph N. Martins
Publikováno v:
Age and Ageing. 44:1012-1019
Background: information provided by an informant about a patient with cognitive change is an essential component of clinical history taking. How an informant's report relates to the patient's phenomenological experience of memory loss is yet to be un
Autor:
Paul Maruff, Christopher C. Rowe, S. Lance Macaulay, Jennifer B Keogh, Stephanie R. Rainey-Smith, Samantha L. Gardener, Kathryn A. Ellis, David Ames, Alan Rembach, Kevin Taddei, Colin L. Masters, Ralph N. Martins
Publikováno v:
British Journal of Nutrition. 114:1683-1693
FFQ are commonly used to examine the association between diet and disease. They are the most practical method for usual dietary data collection as they are relatively inexpensive and easy to administer. In Australia, the Cancer Council of Victoria FF
Autor:
Qiao-Xin, Li, Victor L, Villemagne, James D, Doecke, Alan, Rembach, Shannon, Sarros, Shiji, Varghese, Amelia, McGlade, Katrina M, Laughton, Kelly K, Pertile, Christopher J, Fowler, Rebecca L, Rumble, Brett O, Trounson, Kevin, Taddei, Stephanie R, Rainey-Smith, Simon M, Laws, Joanne S, Robertson, Lisbeth A, Evered, Brendan, Silbert, Kathryn A, Ellis, Christopher C, Rowe, S Lance, Macaulay, David, Darby, Ralph N, Martins, David, Ames, Colin L, Masters, Steven, Collins, Andrea, Wilson
Publikováno v:
Journal of Alzheimer's Disease. 48:175-187
BACKGROUND: The cerebrospinal fluid (CSF) amyloid-β (Aβ)(1-42), total-tau (T-tau), and phosphorylated-tau (P-tau181P) profile has been established as a valuable biomarker for Alzheimer's disease (AD). OBJECTIVE: The current study aimed to determine